Research Peptide Blend

Wolverine Stack

Wolverine Stack is a research blend of two peptides, TB-500 and BPC-157, supplied together in one vial. Atlas RND supplies it as a lyophilized tb-500 + bpc-157 blend · 20 mg for laboratory research use only.

Read the 21 published studies

Last updated

For laboratory research use only. The literature below is provided for educational reference by qualified researchers. It is not medical advice, and nothing on this page is a claim about Wolverine Stack. Not for human or veterinary use.

Published research · 21 studies

Published research on Wolverine Stack

Peer-reviewed studies grouped by what they investigated, with human clinical trials first, then reviews, then laboratory work. Each links to the original paper.

No published study examines Wolverine Stack as a blend. The studies below are on each of its components, BPC-157 and TB-500, studied on their own.

BPC-157 research 13 studies

Open the BPC-157 research page →

Human case series Alternative Therapies in Health and Medicine · 2021

Study title: Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain.

PMID 34324435
Read the study ↗
Human pilot study Alternative Therapies in Health and Medicine · 2025

Study title: Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study.

PMID 40131143
Read the study ↗
Systematic review HSS Journal · 2025

Study title: Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review.

DOI 10.1177/15563316251355551 · PMID 40756949
Read the study ↗
Review Sports Medicine · 2026

Study title: Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.

DOI 10.1007/s40279-026-02437-0 · PMID 41966639
Read the study ↗
Review Current Reviews in Musculoskeletal Medicine · 2025

Study title: Regeneration or Risk? A Narrative Review of BPC-157 for Musculoskeletal Healing.

DOI 10.1007/s12178-025-09990-7 · PMID 40789979
Read the study ↗
Review Cell and Tissue Research · 2019

Study title: Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.

DOI 10.1007/s00441-019-03016-8 · PMID 30915550
Read the study ↗
Animal study Journal of Orthopaedic Research · 2003

Study title: Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth.

DOI 10.1016/S0736-0266(03)00110-4 · PMID 14554208
Read the study ↗
Laboratory study Journal of Applied Physiology · 2011

Study title: The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration.

DOI 10.1152/japplphysiol.00945.2010 · PMID 21030672
Read the study ↗
Review Frontiers in Pharmacology · 2021

Study title: Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.

DOI 10.3389/fphar.2021.627533 · PMID 34267654
Read the study ↗
Review Gut and Liver · 2020

Study title: Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future

DOI 10.5009/gnl18490
Read the study ↗
Laboratory study Journal of Molecular Medicine · 2017

Study title: Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation.

DOI 10.1007/s00109-016-1488-y · PMID 27847966
Read the study ↗
Review Current Neuropharmacology · 2016

Study title: Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.

DOI 10.2174/1570159x13666160502153022 · PMID 27138887
Read the study ↗
Review Pharmaceuticals · 2025

Study title: Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent Review.

DOI 10.3390/ph18020185 · PMID 40005999
Read the study ↗

TB-500 research 8 studies

Open the TB-500 research page →

Animal study Journal of Investigative Dermatology · 1999

Study title: Thymosin beta4 accelerates wound healing.

DOI 10.1046/j.1523-1747.1999.00708.x · PMID 10469335
Read the study ↗
Review Clinical Ophthalmology · 2007

Study title: Thymosin beta 4: A novel corneal wound healing and anti-inflammatory agent.

PMID 19668473
Read the study ↗
Animal and human study Cardiovascular Research · 2025

Study title: Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusion.

DOI 10.1093/cvr/cvaf223 · PMID 41229390
Read the study ↗
Animal study Nature · 2004

Study title: Thymosin beta4 activates integrin-linked kinase and promotes cardiac cell migration, survival and cardiac repair.

DOI 10.1038/nature03000 · PMID 15565145
Read the study ↗
Animal study Nature · 2007

Study title: Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization.

DOI 10.1038/nature05383 · PMID 17108969
Read the study ↗
Review Sports Medicine · 2026

Study title: Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.

DOI 10.1007/s40279-026-02437-0 · PMID 41966639
Read the study ↗
Review Annals of the New York Academy of Sciences · 2007

Study title: Thymosin beta4: actin regulation and more.

DOI 10.1196/annals.1415.008 · PMID 17947588
Read the study ↗
Laboratory study Biochemical and Biophysical Research Communications · 2013

Study title: G-actin sequestering protein thymosin-β4 regulates the activity of myocardin-related transcription factor.

DOI 10.1016/j.bbrc.2013.06.069 · PMID 23811404
Read the study ↗

Important research notice. These studies are posted for research reference only. Titles are reproduced exactly as their authors published them and describe what those researchers investigated; they are not claims by Atlas RND about any product. Not for human consumption. All literature is provided for educational reference only and must not be interpreted as medical advice or product claims. Studies of a compound by other groups are not studies of Atlas RND material. By purchasing from Atlas RND you confirm you are a qualified researcher and will use products in accordance with all applicable laws and regulations. Back to the research library →

Molecular profile

TypeLyophilized peptide blend
ComponentsTB-500 (thymosin β4 fragment) · BPC-157
Total peptide mass20 mg
CompositionPLACEHOLDER — per-component masses on the certificate
CertificateCertificate of conformance, per lot

Quality and lot testing

Current lotWOLV-20-252-26
Purity (current lot)99.38%
LaboratoryFreedom Diagnostics Testing
ReportedOct 1, 2026
Certificate of Analysis for lot WOLV-20-252-26 →

Related compounds

Retatrutide · NAD+ · Tirzepatide · Glow · BPC-157 · TB-500 · GHK-Cu · DSIP · MOTS-C · Wolverine Stack product page